부산대학교 도서관

Kieh M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Richert L; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Beavogui AH; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Grund B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Leigh B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; D'Ortenzio E; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Doumbia S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lhomme E; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Sow S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Vatrinet R; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Roy C; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Kennedy SB; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Faye S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lees S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Millimouno NP; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Camara AM; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Samai M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Deen GF; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Doumbia M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Espérou H; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Pierson J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Watson-Jones D; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Diallo A; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Wentworth D; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; McLean C; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Simon J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Wiedemann A; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Dighero-Kemp B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Hensley L; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lane HC; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Levy Y; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Piot P; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Greenwood B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Chêne G; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Neaton J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Yazdanpanah Y; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE